Detalhe da pesquisa
1.
At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity.
J Immunol
; 209(1): 16-25, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705253
2.
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis.
Ann Rheum Dis
; 83(2): 267-270, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788903
3.
Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification.
Ann Rheum Dis
; 78(7): 908-916, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151934
4.
Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis.
Ann Rheum Dis
; 2022 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459696
5.
Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts.
JCI Insight
; 8(20)2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725442
6.
Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation.
Sci Adv
; 8(6): eabm1759, 2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138894
7.
Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.
PLoS One
; 16(3): e0247847, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784344
8.
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load.
Arthritis Res Ther
; 23(1): 230, 2021 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479638